Strategic Partnerships AlloSource operates a large tissue network with a focus on allografts for bone, skin, and soft tissue, presenting a sales opportunity for strategic partnerships with hospitals, surgical centers, and cartilage/pain management clinics to expand use of their AlloConnex tendon, ligament, and fascia products.

Product Expansion Recent launches such as ReConnex Pre-Sutured Tendon and AceConnex Pre-Sutured Fascia indicate a growth trajectory in pre-sutured tissue devices, suggesting cross-sell opportunities to surgeons and OR teams adopting advanced tissue products for tendons, fascia, and joint reconstruction.

Cartilage Focus A strong emphasis on cartilage solutions and joint preservation, including ViaTrue cryopreservation research and ProChondrix CR osteochondral allografts, points to targeting orthopedic centers of excellence and ICRS-aligned institutions for procurement and collaboration.

Clinical Adoption Participation in major conferences (ICRS World Congress) and ongoing clinical outcome reporting create openings for thought leadership programs, case-based selling, and advisory collaborations to accelerate adoption of AlloSource cartilage and burn/skin allografts.

Operational Readiness As a nonprofit with a sizable revenue base and a robust tech stack (ELK, Snowflake, Azure DevOps), there is potential to help procurement teams optimize supply reliability, inventory management, and patient-need forecasting for ready-to-use allograft products.